GlassScriptPhysician profile
Norma S Porter
NPI 1750412003
$8,998.95
in general payments reported to CMS, 2019-2025
12 companies · $689 in 2025
The $689 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,071 · 2022: $5,065 · 2023: $921 · 2024: $1,253 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,862.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $5,126.15 | 2021-2025 | Biktarvy, Sunlenca |
| Viiv Healthcare Company | $2,087.25 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Janssen Biotech, INC. | $380.59 | 2021-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $373.81 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Products, LP | $329.76 | 2022-2023 | Symtuza |
| Emd Serono, INC. | $275.68 | 2021-2025 | Serostim |
| Theratechnologies INC. | $132.67 | 2021-2024 | Egrifta, Trogarzo |
| Corcept Therapeutics | $117.09 | 2024 | Korlym |
| Janssen Scientific Affairs, LLC | $116.17 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Pfizer INC. | $15.88 | 2024 | |
| Inogen, INC. | $15.42 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.